Name
GS1-06 - A Randomized Controlled Phase Ill Trial of Entinostat, a Class I Selective Histone Deacetylase Inhibitor, in Combination with Exemestane in Patients with Hormone Receptor Positive Advanced Breast Cancer
Date & Time
Tuesday, December 7, 2021
Speakers
Virtual Session Link